Gardiner, C;
Longair, I;
Pescott, MA;
Erwin, H;
Hills, J;
Machin, SJ;
Cohen, H;
(2009)
Self-monitoring of oral anticoagulation: does it work outside trial conditions?
Journal of Clinical Pathology
, 62
(2)
168 - 171.
10.1136/jcp.2008.059634.
Preview |
Text
Gardiner_Self-monitoring of oral anticoagulation%3A does it work outside trial conditions%3F.pdf Download (206kB) | Preview |
Abstract
Background: Patient self-monitoring (PSM) of oral anticoagulation therapy (OAT) can improve anticoagulant control, but poor uptake and high dropout rates have prompted suggestions that PSM is suitable for only a minority of patients in the UK.Aims: To determine whether PSM could be a viable alternative to regular hospital anticoagulant clinic attendance, if offered from the start of treatment.Methods: 318 consecutive patients referred, for the first time, to an anticoagulation clinic were assessed for eligibility using established criteria. Patients electing for PSM attended training and, following successful assessment, performed a capillary blood INR every two weeks or more frequently if directed to do so by the anticoagulation clinic. Primary outcome measures were uptake of PSM and the percentage time in target therapeutic INR range (TIR) compared to patients electing for routine clinic care.Results: Of 318 patients referred for OAT, 188 were eligible for PSM. 84 (26%) elected to self-monitor, of whom 72 (23%) remained self-monitoring or had completed their course of treatment at the end of the audit. Self-monitoring patients had significantly better anticoagulant control than those receiving routine hospital anticoagulation clinic care (TIR 71% vs 60%, p = 0.003) and significantly less time outside critical limits, ie, INR< 1.5 or >5.0 (0.45% vs 2.04%, p = 0.008).Conclusions: Patients offered PSM from the start of treatment show increased uptake compared to previous UK studies and a level of oral anticoagulation control comparable to that reported in previous clinical trials.
| Type: | Article |
|---|---|
| Title: | Self-monitoring of oral anticoagulation: does it work outside trial conditions? |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/jcp.2008.059634 |
| Publisher version: | http://dx.doi.org/10.1136/jcp.2008.059634 |
| Language: | English |
| Additional information: | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported Licence (https://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, and that it is not used for commercial purposes. |
| Keywords: | randomized-trial, management, therapy, warfarin, guidelines, intensity, quality |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1331371 |
Archive Staff Only
 |
View Item |
